A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
NCT 05503797 Brief Summary The objective of this Master Protocol is to…
Read more arrow_forwardNCT 05503797 Brief Summary The objective of this Master Protocol is to…
Read more arrow_forwardNCT 05205109 Brief Summary This is a study of ATG-037 Monotherapy and…
Read more arrow_forwardNCT 04913285 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardNCT 05487235 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardNCT 04449874 Brief Summary This is a Phase I dose-escalation and dose-expansion…
Read more arrow_forwardNCT 06004245 Brief Summary This is a first-in-human, Phase I, open-label, multicenter,…
Read more arrow_forwardNCT 06004245 Brief Summary This is a first-in-human, Phase I, open-label, multicenter,…
Read more arrow_forwardNCT 06326411 Brief Summary This is a two-part Phase 1, open label,…
Read more arrow_forwardNCT 06533059 Brief Summary The purpose of this study is to characterize…
Read more arrow_forwardNCT 06760819 Brief Summary Researchers are looking for a better way to…
Read more arrow_forward